Additionally, the favorable effects of FLX on body weight gain, visceral adiposity, and glucose metabolism may indicate an influence on GLP-1 receptor function similar to pharmaceutical treatments for diabetes and obesity. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.